Literature DB >> 18418072

SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail.

Yinliang Yin1, Vivian C Yu, Guang Zhu, Donald C Chang.   

Abstract

We report evidence suggesting that methyltransferase SET8 plays a novel role in regulating cell cycle by suppressing DNA replication through histone binding. First, the distribution of SET8 is strongly cell cycle-dependent. SET8 was concentrated in the nucleus during G(1) and G(2) phases, and was excluded from the nucleus during S phase. Second, at G(1)/S transition, SET8 was degraded through ubiquitination via SCF/Skp2. Third, it was evident that the SET8 binds to the H4 N-terminal tail (H4NT) and blocks the acetylation of lysine residues K5, K8 and K12 of histone H4 during G(1). Such a blockage can hinder DNA replication. Fourth, SET8 binds to hypoacetylated but not hyperacetylated H4NT. Finally, overexpressing the histone-binding domain of SET8 appeared to suppress DNA replication and arrest the cell cycle before the G(1)/S transition. Taken together, these findings suggest that SET8 can be a negative regulator of DNA replication and the destruction of SET8 is required for the onset of S phase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418072     DOI: 10.4161/cc.7.10.5867

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

1.  Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage.

Authors:  Hisanobu Oda; Michael R Hübner; David B Beck; Michiel Vermeulen; Jerard Hurwitz; David L Spector; Danny Reinberg
Journal:  Mol Cell       Date:  2010-10-28       Impact factor: 17.970

Review 2.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

Review 3.  Orchestration of late events in erythropoiesis by KLF1/EKLF.

Authors:  Merlin Nithya Gnanapragasam; James J Bieker
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

Review 4.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.

Authors:  Courtney G Havens; Johannes C Walter
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

5.  Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation.

Authors:  Jeffrey Malik; Michael Getman; Laurie A Steiner
Journal:  Mol Cell Biol       Date:  2015-04-06       Impact factor: 4.272

6.  Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.

Authors:  Xiaoqing Cheng; Yuan Hao; Wenjie Shu; Mengjie Zhao; Chen Zhao; Yuan Wu; Xiaodan Peng; Pinfang Yao; Daibiao Xiao; Guoliang Qing; Zhengying Pan; Lei Yin; Desheng Hu; Hai-Ning Du
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

7.  Memory CD4+ T-cell-mediated protection depends on secondary effectors that are distinct from and superior to primary effectors.

Authors:  Tara M Strutt; K Kai McKinstry; Yi Kuang; Linda M Bradley; Susan L Swain
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

8.  CRL4(CDT2) targets CHK1 for PCNA-independent destruction.

Authors:  Jiwon Huh; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

9.  The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21.

Authors:  Keishi Fukuura; Yasumichi Inoue; Chiharu Miyajima; Shin Watanabe; Muneshige Tokugawa; Daisuke Morishita; Nobumichi Ohoka; Masayuki Komada; Hidetoshi Hayashi
Journal:  J Biol Chem       Date:  2019-09-18       Impact factor: 5.157

Review 10.  A new regulator of the cell cycle: the PR-Set7 histone methyltransferase.

Authors:  Shumin Wu; Judd C Rice
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.